ANN ARBOR – Michigan Medicine announced in an email to staff on Monday that it has expanded the Phase 1A COVID-19 vaccine priority group after administering more than 11,000 vaccines since Dec. 14.
Based on recommendations from the state, those now eligible for a Phase 1A vaccine at University of Michigan include:
- Anyone serving in a role at Michigan Medicine or University of Michigan who works in a clinical setting (i.e. hospital, ambulatory clinic, home care) and is not able to work exclusively remotely is able to receive a COVID-19 vaccine now as part of Phase 1A.
- Anyone serving in a role at University of Michigan in a clinical setting and not able to work exclusively remotely can also receive a COVID-19 vaccine now as part of Phase 1A. This includes staff and students working in the following areas: University Health Services, Dentistry, Nursing, Social Work, Kinesiology, Public Health, Pharmacy and others who are working in a clinical environment.
“There will be enough vaccine for everyone and we are expecting new shipments each week,” read the email.
As of 9 a.m. on Monday, Michigan Medicine reported the following vaccine data:
- Number of total vaccine doses received by University of Michigan: 11,950
- Number of vaccines administered to U-M community: 10,900
- Number of vaccines administered to U-M community on Sunday, Jan. 3: 870
- Number of vaccine appointments currently scheduled for Monday, Jan. 4 and Tuesday, Jan. 5: 1,594
With a new shipment of vaccines expected on Tuesday, Michigan Medicine estimates it will schedule the last of its current Phase 1A group through Jan. 12.
Michigan Medicine is administering vaccines seven days a week. On Thursday, Michigan Stadium opened as a new vaccination site, which will play a central role in inoculating tens of thousands of people as the healthcare system receives more doses of the vaccine.